Literature DB >> 17459514

Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model.

Yoshihiro Kamada1, Hitoshi Matsumoto, Shinji Tamura, Juichi Fukushima, Shinichi Kiso, Koji Fukui, Takumi Igura, Norikazu Maeda, Shinji Kihara, Tohru Funahashi, Yuji Matsuzawa, Iichiro Shimomura, Norio Hayashi.   

Abstract

BACKGROUND/AIMS: Adipose tissue produces a number of adipocytokines, including adiponectin, leptin, and tumor necrosis factor-alpha. Obesity, which is associated with low plasma adiponectin levels, is an independent risk factor for various liver diseases including nonalcoholic steatohepatitis (NASH). The aim of this study was to examine the effects of adiponectin on the progression of NASH to cirrhosis and tumor formation using adiponectin-knockout (KO) mice.
METHODS: Using a choline-deficient L-amino acid-defined (CDAA) diet-induced mouse NASH model, liver histology and oxidative stress markers were investigated in KO and wild-type (WT) mice.
RESULTS: Hepatic steatosis was enhanced to a greater extent in KO mice, compared to WT mice after a 1-week CDAA diet. After 24 weeks, 6 out of 14 KO mice developed liver cirrhosis and hepatic tumors, whereas the 15 WT mice showed only simple steatosis. In KO mice, hepatic cytochrome P450 2E1 levels were upregulated, and markers of oxidative stress (thiobarbituric acid reactive substances, 8-hydroxydeoxyguanosine-positive cells) were significantly increased compared with WT mice.
CONCLUSIONS: Our results indicate that lack of adiponectin enhances the progression of hepatic steatosis, fibrosis, and hepatic tumor formation in an animal model of NASH. Hypoadiponectinemia in obesity could be a risk factor for NASH-related hepatic tumor formation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17459514     DOI: 10.1016/j.jhep.2007.03.020

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  57 in total

Review 1.  The balance between leptin and adiponectin in the control of carcinogenesis - focus on mammary tumorigenesis.

Authors:  Michael E Grossmann; Margot P Cleary
Journal:  Biochimie       Date:  2012-06-20       Impact factor: 4.079

Review 2.  Inflammation and fibrogenesis in steatohepatitis.

Authors:  Hideki Fujii; Norifumi Kawada
Journal:  J Gastroenterol       Date:  2012-02-07       Impact factor: 7.527

Review 3.  Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Sanja Stojsavljević; Marija Gomerčić Palčić; Lucija Virović Jukić; Lea Smirčić Duvnjak; Marko Duvnjak
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

4.  Absence of invariant natural killer T cells deteriorates liver inflammation and fibrosis in mice fed high-fat diet.

Authors:  Takuya Miyagi; Tetsuo Takehara; Akio Uemura; Kumiko Nishio; Satoshi Shimizu; Takahiro Kodama; Hayato Hikita; Wei Li; Akira Sasakawa; Tomohide Tatsumi; Kazuyoshi Ohkawa; Tatsuya Kanto; Naoki Hiramatsu; Norio Hayashi
Journal:  J Gastroenterol       Date:  2010-07-02       Impact factor: 7.527

Review 5.  Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer.

Authors:  Jessica Tsuei; Thinh Chau; David Mills; Yu-Jui Yvonne Wan
Journal:  Exp Biol Med (Maywood)       Date:  2014-06-20

Review 6.  Preclinical models of non-alcoholic fatty liver disease.

Authors:  Prasanna K Santhekadur; Divya P Kumar; Arun J Sanyal
Journal:  J Hepatol       Date:  2017-11-09       Impact factor: 25.083

Review 7.  Obesity and cancer--mechanisms underlying tumour progression and recurrence.

Authors:  Jiyoung Park; Thomas S Morley; Min Kim; Deborah J Clegg; Philipp E Scherer
Journal:  Nat Rev Endocrinol       Date:  2014-06-17       Impact factor: 43.330

Review 8.  Mouse models for liver cancer.

Authors:  Latifa Bakiri; Erwin F Wagner
Journal:  Mol Oncol       Date:  2013-02-05       Impact factor: 6.603

9.  Leptin induces an inflammatory phenotype in lean Wistar rats.

Authors:  Monique Allman; Mathew Wallace; Latausha Gaskin; Chantal A Rivera
Journal:  Mediators Inflamm       Date:  2010-01-26       Impact factor: 4.711

Review 10.  Targeting obesity-related adipose tissue dysfunction to prevent cancer development and progression.

Authors:  Ayca Gucalp; Neil M Iyengar; Clifford A Hudis; Andrew J Dannenberg
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.